<?xml version="1.0" encoding="UTF-8"?>
<p>In the late 1970s, a 14-valent Pneumococcal Polysaccharide Vaccine (PPV) was registered in the United States, containing purified polysaccharides of 14 pneumococcal serotypes (1, 2, 3, 4, 6A, 7F, 8, 9N, 12F, 14, 18C, 19F, 23F, and 25F) [
 <xref rid="B65-vaccines-07-00168" ref-type="bibr">65</xref>,
 <xref rid="B66-vaccines-07-00168" ref-type="bibr">66</xref>]. In 1983, this vaccine was replaced by a 23-valent PPV (PPV23) [
 <xref rid="B66-vaccines-07-00168" ref-type="bibr">66</xref>]. However, the polysaccharides pneumococcal vaccines were not effective in younger children and were not able to induce herd immunity.
</p>
